Notice of Capital Markets Day and Site Visit

RNS Number : 3709S
Benchmark Holdings PLC
14 July 2022
 

 

 

14 July 2022

 

Benchmark Holdings plc

 

("Benchmark", the "Company" or the "Group")

 

 

Notice of Capital Markets Day and Site Visit

 

 

Benchmark Holdings plc (LSE:BMK),   the leading aquaculture biotechnology company, announces that it is hosting a Capital Markets Day and Site Visit for investors and analysts on Tuesday, 20 September 2022, from 9:00 CEST in Bodø and Salten, Norway, the site of the Group's state of the art, land based salmon genetics facility.

 

During the event, Trond Williksen CEO and Septima Maguire CFO, together with other members of the Benchmark senior management team, will elaborate on the operations and strategy of its three business areas, Genetics, Advanced Nutrition and Health, and on the long-term strategy and financial targets for the Group. After the presentations, which will take place from 9:00am to 12:00pm CEST in Bodø, participants will be invited to join a site visit to the Company's nearby salmon genetics facility in Salten and transport will be provided between Bodø and Salten. The day is expected to conclude in Bodø at 20:00 CEST.

 

An agenda for the Capital Markets Day, transport information, as well as information on participating remotely via a webcast, will be made available closer to the event date. A recording of the Capital Markets Day and presentation materials will be available on the Company's website after the event.

 

For further details, and to register your interest to attend this event, please contact MHP Communications via email at benchmark@mhpc.com .

 

 

 

- ENDS -

 

 

 

Enquiries:

 

Benchmark Holdings plc

Via benchmark@mhpc.com

Trond Williksen, CEO


Septima Maguire, CFO


Ivonne Cantu, Investor Relations




Numis (Broker and NOMAD)

Tel: +44 (0)20 7260 1000

James Black / Freddie Barnfield / Duncan Monteith




MHP


Katie Hunt / Reg Hoare / Charlie Protheroe

Tel: +44 (0)20 3128 8100

Via benchmark@mhpc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBNBBKDFOD
UK 100

Latest directors dealings